Evidence map›Paper›PMID 38663944›Full record

ArticleThe lancet. Diabetes & endocrinology2024

Endpoints for clinical trials in type 1 diabetes drug development.

Alfonso Galderisi, Brynn E Marks, Linda A DiMeglio, Carine de Beaufort

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The lancet. Diabetes & endocrinology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Article
  3. Call for Standardization of C-Peptide Measurement.Journal of diabetes science and technology · 2025
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Alfonso GalderisiPediatric Endocrinology and Diabetes, Department of Pediatrics, Yale University, New Haven, CT, USA.
Brynn E MarksDivision of Endocrinology and Diabetes, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Linda A DiMeglioDivision of Pediatric Endocrinology and Diabetology, Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, IN, USA.
Carine de BeaufortDiabetes & Endocrine Care Clinique Pédiatrique, Clinique Pédiatrique Centre Hospitalier de Luxembourg, 1210 Luxembourg City, Luxembourg; Faculty of Science, Technology and Medicine, University of Luxembourg, Esch-Belval, Luxembourg. Electronic address: bcschim@pt.lu.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Developing a patient-centered psychoeducational tool to realize the potential of diabetes technologiesK23DK129827 · NIDDK · CHILDREN'S HOSP OF PHILADELPHIA · PI MARKS, BRYNN E · 2022 to 2025
$842k
NCATS NIH HHS UL1 TR001863NIDDK NIH HHS K23 DK129827
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38663944
PMCPMC11230104

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.